Paget-Schroetter disease overview: Difference between revisions

Jump to navigation Jump to search
Gunnam (talk | contribs)
Gunnam (talk | contribs)
Line 15: Line 15:


==Causes==
==Causes==
Common causes of [[Paget-Schroetter disease]] include a repetitious activity of [[Upper limb|upper extremity]], hypertrophied [[scalenus anterior muscle]], presence of [[osseous]] [[exostosis]], [[congenital deformities]], and major [[vein]] [[catheterization]].


==Differentiating Xyz from Other Diseases==
==Differentiating Xyz from Other Diseases==

Revision as of 13:51, 21 June 2020

Paget-Schroetter disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Paget-Schroetter disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Paget-Schroetter disease overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Paget-Schroetter disease overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Paget-Schroetter disease overview

on Paget-Schroetter disease overview

Paget-Schroetter disease overview in the news

Blogs on Paget-Schroetter disease overview

Directions to Hospitals Treating Paget-Schroetter disease

Risk calculators and risk factors for Paget-Schroetter disease overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Historical Perspective

Spontaneous axillary-subclavian vein thrombosis (ASVT) has been first described by Cruveilhier. Sir James Paget identified the subclavian vein thrombosis in one of his patients. Hughes created the term "Paget-Schroetter".

Classification

There is no established system for the classification of Paget-Schroetter disease.

Pathophysiology

It is thought that Paget-Schroetter disease is a form of axillary-subclavian vein thrombosis resulted from compression of aforementioned veins. This condition is more common in athletes and/or manual labors. Some studies link Paget-Schroetter disease with anatomical defects involving the thoracic outlet.

Causes

Common causes of Paget-Schroetter disease include a repetitious activity of upper extremity, hypertrophied scalenus anterior muscle, presence of osseous exostosis, congenital deformities, and major vein catheterization.

Differentiating Xyz from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Based on pathophysiology of the Paget-Schroetter disease, extrinsic compression and endothelial damage to the vein are among the underlying problems that should be addressed. While thrombolysis only treats acute symptoms, correction surgery decreases recurrence in patients with suspected subclavian vein entrapment. Correction surgery involves both thoracic outlet decompression and restoration of vein patency.

Primary Prevention

There are no established measures for the primary prevention of Paget-Schroetter disease.

Secondary Prevention

There are no established measures for the secondary prevention of Paget-Schroetter disease.

References

Template:WH Template:WS